ananyo writes "Gene patents have been upheld in a landmark case over two genes associated with hereditary forms of breast and ovarian cancer.
The lawsuit against Myriad Genetics, a diagnostic company, based in Salt Lake City, Utah, that holds patents on the genes BRCA1 and BRCA2, has bounced from court to court since 2010. In a 2-1 decision today, a federal appeals court reaffirmed their latest decision that genes represent patent-eligible matter. As noted before on slashdot, the case will have major implications for cancer researchers, patients and drug makers."
Link to Original Source